Avsnitt
-
In this episode, we explore why geography is more than a backdrop—it is a strategic lever in early phase oncology trials. From patient access and regulatory timelines to investigator expertise and data governance, every decision about trial placement can accelerate or stall innovation.
Join host Maria Garcia and Ken Morrison, as they unpack how Fortrea’s EPON Network optimizes site selection to deliver speed, precision, and confidence in early phase studies. -
In this episode of Accelerating Oncology – Inside the EPON Network, host Maria Garcia discusses why partnerships matter in early phase oncology. We’ll also find out what makes an EPON site different and talk about partnership design principles.
Host: María García Requesens, Medical Director Fortrea
Participants: Dr. William McKean, Medical Oncologist and Principal Investigator at The START Center for Cancer Research and Anne Himmel, Senior Manager, Site Engagement and Partnership Delivery at Fortrea -
Early Phase Oncology trials have evolved from simple safety checks to the most scientifically demanding stage of cancer drug development. In this episode of Accelerating Oncology – Inside the EPON Network, host Ken Morrison and guest María García unpack why Phase 1 trials are no longer “entry-level” and why they require a specialized model for success.
